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A transcriptional activator can suppress gene expression by interfering with transcription initiated
by another activator. Transcriptional interference has been increasingly recognized as a regulatory
mechanism of gene expression. The signals received by the two antagonistically acting activators
arecombinedbythepolymerasetrafﬁckingalongtheDNA. Wehavedesigned adual-control genetic
system in yeast to explore this antagonism systematically. Antagonism by an upstream activator
bears the hallmarks of competitive inhibition, whereas a downstream activator inhibits gene
expression non-competitively. When gene expression is induced weakly, the antagonistic activator
can have a positive effect and can even trigger paradoxical activation. Equilibrium and non-
equilibrium models of transcription shed light on the mechanism by which interference converts
signals, and reveals that self-antagonism of activators imitates the behavior of feed-forward loops.
Indeed, a synthetic circuit generates a bell-shaped response, so that the induction of expression is
limitedtoanarrowrangeoftheinputsignal.Theidentiﬁcationofconservedregulatoryprinciplesof
interference will help to predict the transcriptional response of genes in their genomic context.
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Introduction
One of the major goals of quantitative modeling of gene
regulation is to predict gene expression based on the
occupancy of gene regulatory sites by transcriptional factors.
The action of transcriptional activators and repressors bound
to a promoter can be represented as a mathematical operation.
These operations have been systematically analyzed in
prokaryotes (Buchler et al, 2003; Hermsen et al, 2006; Cox
et al, 2007), and in eukaryotes (Ratna et al, 2009).
The above models focused on the classical role of transcrip-
tional activators: the enhancement of gene expression.
Interestingly, activators can also suppress gene expression
by, at least, two different mechanisms (Shearwin et al, 2005).
First, intergenic transcription initiated by activators from
upstream sequences can interfere with the expression of
downstream genes. This upstream interference has been
observed for the SER3, ADH1 and ADH3 genes in yeast
(Martens et al, 2004, 2005; Bird et al, 2006). Intergenic
transcription produces noncoding RNAs that have been
detected in Saccharomyces cerevisiae and higher eukaryotes
in large numbers (Hongay et al, 2006; Khaitovich et al, 2006;
Neil et al, 2009; Xu et al, 2009). Positive regulatory aspects of
transcriptional interference have been increasingly recognized
in processes and phenomena, such as T-cell receptor recombi-
nation, latency of the HIV infection and epigenetic cellular
memory (Schmitt et al, 2005; Abarrategui and Krangel, 2007;
Lenasi et al, 2008).
Second, when an activator binds to a site that overlaps or is
positioned downstream of the transcriptional initiation site, it
can interfere with transcriptional initiation and elongation.
This downstream antagonism is exempliﬁed by the ZRT2,
PRY3 and ACC1 genes (Li and Johnston, 2001; Bird et al, 2004;
Bickel and Morris, 2006).
Signals passed onto transcriptional activators that either
interfere with transcriptional initiation or initiate intergenic
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which is mediated predominantly by the polymerase. Little is
known about how these antagonistic signals are combined.
Using the yeast, Saccharomyces cerevisiae, as a eukaryotic
model organism, we have explored the principles of this signal
conversion and how these signals can be utilized to control
gene expression.
Results and discussion
Competitive inhibition by upstream interference
We studied upstream transcriptional interference using chro-
mosomally integrated gene constructs. In these constructs,
intergenic transcription interferes with the expression of a
downstream GFP reporter gene under the control of different
promoters (Figure 1, Materials and methods section). The
intergenic transcription was triggered by the transcriptional
activator GEV, activity of which was modulated by estradiol.
First, we used the ADH1 promoter, which has been already
shown to be regulated by interference at its original genomic
locus (Bird et al, 2006). On activation of GEV using estradiol,
the GFPexpression driven by the ADH1 promoter decreased in
a graded way, so that the expression had a unimodal
distribution in the cell population (Figure 1A, Supplementary
Figure S8). Thus, the mean expression level can be adequately
used to quantify the output of the system.
Next, we measured the changes in the mean GFPexpression
as the occupancy of the activator-binding sites within a
downstream promoter was varied. For this purpose, doxycy-
cline was used to modulate the binding of the transcriptional
activator, rtTA, to two tet operators within the downstream
promoter. The doxycycline-induced binding of rtTA to the
promoter led to GFP expression (Figure 1B). We observed that
the suppression of GFP expression by intergenic transcription
was graduallyrelievedas the rtTA binding strengthened,when
Figure 1 Upstream interference by intergenic transcription. (A) The 1000-bp long PADH1 includes an upstream TATA box ( 936bp, checkered diamond), which is
required to drive the intergenic transcription. Single cell distribution of GFP expression driven by GALUAS-PADH1( 1000 to  1) (YAntH44.6) is shown when intergenic
transcription was activated at different estradiol concentrations. Relative cell count is shown. (B) The upstream activating sequence (UAS) of GAL1, GALUAS, was
positioned upstreamof thetruncated EGT2gene(EGT2 115to509) toemulate intergenic transcription. Thetruncated genecomprises thecore promoter withaTATA
box ( 115 to 0) and part of the ORF (1–509). The downstream promoter was obtained by fusing the [tetO]2 to the GAL1 or CYC1 core promoters including a TATA box
(YABH39.4 and  38.2). Expression was induced by doxycycline at different ﬁxed concentrations of estradiol. Error bars represent s.d. values calculated from three
experiments. The curves represent ﬁts of the non-equilibrium model of upstream interference (see Supplementary Information), with a¼3, kON¼0.015nM
 1min
 1;
kb¼1min
 1,Z¼49.6,kr¼0.041min
 1,kS¼10min
 1,m¼33.4.Atot¼9.9nMandKind¼6.1toaccountfortheinductionbydoxycycline,andP¼0,1.5,3.5,8.6and71for
therespectiveestradiolconcentrations. kOFF¼0.11min
 1,b¼2.8,bas¼0.0055,vmax¼201forP[tetO]2-GAL1TATA;andkOFF¼0.07min
 1,b¼7,bas¼0.03,andvmax¼230
forP[tetO]2-CYC1TATA.(C)Constructsusedtomeasureterminationefﬁciency.ThearrowheaddenotestheACT1transcriptional terminator.Thedownstreampromoterwas
obtained by inserting ﬁve tet operators into the EGT2 promoter. (D) Expression was induced by 2mM doxycycline and was inhibited by increasing concentrations of
estradiol.DataareshownforGALUAS-EGT2( 115to509)-P[tetO]5inEGT2(YAntH41.1,redsquares)andGALUAS-EGT2( 115to509)-TACT1–P[tetO]5inEGT2(YAntH42.1,
blue triangles). (E) The termination efﬁciency was calculated from two independent experiments (see Materials and methods section) using the data as shown in (D).
(F) Activation of gene expression by GEV when only the TACT1 separates the GALUAS from P[tetO]5inEGT2 (YAntH43.1). Source data is available for this ﬁgure at
www.nature.com/msb.
Antagonism of transcriptional activators
A Buetti-Dinh et al
2 Molecular Systems Biology 2009 & 2009 EMBO and Macmillan Publishers Limitedthe doxycycline concentration was increased from intermedi-
ate to high levels (Figures 1B and 2B). This indicates that
intergenic transcription competes with the rtTA-driven tran-
scription.
We compared the expression data obtained at different
strengths of intergenic transcription with basic equilibrium
models of repression (Box 1). The data agreed well with the
model of competitive inhibition, at weak and moderate
intergenic transcription (Figure 2A and B). The drop of
inhibition efﬁciency close to saturation of activator-binding
sites, a hallmark of competitive inhibition, was particularly
pronounced with a promoter containing seven operators
(Figure 2C and Supplementary Figure S9C and D), in which
a higher degree of operator occupancy can be attained due to
cooperative binding of rtTA (Becskei et al, 2005). The
overwhelming majority of the data points aligned closely with
the ﬁtted curves calculated from the equilibrium competition
model (Figure 2C).
Theequilibriumcompetitionmodeldidnotﬁtthedatawhen
interference was strong (Supplementary Figure S10). In this
case, a good ﬁt was obtained only to the data points measured
at high concentration of doxycycline (Figure 2B and C). When
these ﬁts were extended into the range of low doxycycline
concentrations, they overestimated the inhibition of gene
expression, suggesting that intergenic transcription can have a
positive effect on GFP expression (Figure 2B and C). To
evaluate how general the above observations are, we studied
interference when expression at the downstream promoter
was driven by various activation domains (VP16 and Swi5)
and by various core promoters (CYC1, GAL1 and EGT2). In all
the examined cases, the two hallmarks were conserved, and
only the overall efﬁciencyof inhibition varied (Supplementary
Figure S12); the competition dominated at medium and high
doxycycline concentrations, whereas the positive effect of
strong intergenic transcription was unmasked at a low
doxycycline concentration.
Next, we built a detailed model on the basis of realistic
molecular mechanisms. Previous studies have suggested that
competition by intergenic transcription can arise when the
elongating polymerase occludes the activator-binding sites
(Sneppenetal,2005).Furthermore,theelongatingpolymerase
roadblockedbytheactivatorcanexertaforceontheactivator–
DNA complex and destabilize it, after which the activator
dissociates (Prescott and Proudfoot, 2002; Mosrin-Huaman
et al, 2004; Galburt et al, 2007). However, when the
polymerase traverses binding sites within the promoter, they
can become more accessible, possibly due to changes in the
chromatin structure, which enables the facilitated rebinding of
transcription factors to them (Uhler et al, 2007). It is important
to note that different methods for measuring DNA–protein
interactions can produce contrasting results for the binding of
the same transcription factor, when exposed to intergenic
transcription (Bird et al, 2006). We constructed a non-
Figure 2 Equilibrium (A–C) and non-equilibrium competition models (D–H)o f
upstream interference. (A) Scheme of the equilibrium competition model. The
downstream promoter is occupied either by the interfering polymerase or by the
activator, AUAS. (B, C) Equation (1) (Box 1) was ﬁt to the data. KD
A¼0.37 and
f(R)¼2.9,5.9,14.1*and41.4*forPtetO2-GAL1TATA(datare-plottedfromFigure1B)
(B);KD
A¼0.024 andf(R)¼2.6,5.9,18.5 and42.7* forPtetO7-GAL1TATA(YABH34.5)
(C).Theasteriskedf(R)valueswereobtainedbyﬁttingequation(1)todatapoints
that had a normalized expression higher than 0.4 (see Materials and methods
section).(D)Inthenon-equilibriumcompetitionmodel,theinterferingpolymerase
traverses the UAS and the TATA box in the downstream promoter, after which
they bind the activator, AUAS, and the TBP with a higher afﬁnity. (E) Gene
expression as a function of AUAS was calculated from the non-equilibrium
model with the parameter values ﬁtted for PtetO2-GAL1TATA (Figure 1B). The
concentration of the activator [P] driving the intergenic transcription is color
coded. (F) Curves were re-calculated from (E). (G) Fold inhibition at P¼100 was
calculated for promoters with one (O1) and two (O2) operators as in (F), except
for the parameters speciﬁed in the ﬁgure legend. The red dashed line stands for
one operator with reduced afﬁnity. (H) Fold inhibition was measured at 200nM
estradiol as the doxycycline concentration was varied. The curves were ﬁt with
the parameter values obtained for the corresponding constructs in (Figure 1B).
To link the AUAS concentration to the doxycycline concentration, Atot¼10.3nM
and Kind¼2.6 were ﬁt for promoters with CYC1TATA, measured on the
same day. For PtetO1-CYC1TATA (YABH40.6), kON¼0.0072nM
 1min
 1 and
kOFF¼0.13min
 1 were ﬁtted to account for its lower binding constant in
comparison with PtetO2-CYC1TATA. Source data is available for this ﬁgure at
www.nature.com/msb.
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facilitated by a factor of b, and the increased association of
the TATA-binding protein (TBP) and the above forms of
competition (Figure 2D, Supplementary Figure S1).
The model successfully reproduced the positive effect on
geneexpressionwhilepreservingthehallmarksofcompetition
(Figure 2E and F, Supplementary Figure S2). The model ﬁtted
to data obtained for promoters containing two tet operators
(Figure 1B) also predicts that the peak value of inhibition by
intergenic transcription does not increase when the interfering
polymerase competes with the rtTA bound to only one
operator, or may even decrease if the single operator has a
lower afﬁnity (Figure 2G). Inhibition of expression caused by
strong intergenic transcription reaches its peak value at
intermediate doxycycline concentrations, at which intergenic
transcription can more easily outcompete rtTA-induced
transcription and the positive effect is still negligible. The
above prediction was consistent with the measurements: the
peak inhibition for the tetO1-CYC1TATA construct was lower,
and shifted to higher doxycyline levels in comparison with the
tetO2-CYC1TATA construct (Figure 2H, Supplementary Figure
S11). Similarly, when the number of tet operators, fused to a
GAL1 core promoter, was increased from two to seven, the
inhibitioncurveonlyshiftedtowardslowerdoxycyclinevalues
but its peak value did not change (Figure 2H).
Initiation and termination of transcriptional
interference
The prevalence of interference in thegenomiccontextdepends
onthenumberofDNAsequencesthatcaninitiateinterference,
and on how efﬁciently transcriptional terminators terminate
transcription between adjacent genes to prevent interference.
With some modiﬁcations, the above gene constructs can shed
lightonhowlikelyinterferencearisesat agivensegmentofthe
genome (Supplementary Figure S13).
When two different activators bind to a promoter, both of
them can activate gene expression (Supplementary Figure
S13C). Surprisingly, the insertion of a short, eight-nucleotide
long TATA sequence converts the activator recruited to a site
upstream of the TATA box into an inhibitor of expression
(Supplementary Figure S13B). This inhibition, triggered by a
simple sequence, was less efﬁcient than the inhibition by
intergenic transcription initiated by a full promoter (Supple-
mentary Figure S13A, B and D).
The efﬁciency of termination was extrapolated by measur-
ingtowhat extent interferencewasreduced when aterminator
was inserted between the intergenic transcription unit and
the downstream promoter–GFP constructs (Figure 1C). The
efﬁciency of termination was calculated at intermediate rtTA
binding, when the inhibition of expression is linearly
dependent on estradiol concentration (Figure 1D). The ACT1
transcriptional terminator had a relatively constant, around
80%, termination efﬁciency over a broad range of intergenic
transcriptionrates(Figure1E).Thisconstancyoftheefﬁciency
is surprising because it has been commonly assumed that
terminators fail when the transcription rate passes a threshold
value.
The genomes of yeast species are very compact and
transcriptional terminators often overlap with the promoters
of downstream genes (Valerius et al, 2002). Therefore,
termination efﬁciency inferred from the changes in transcrip-
tional interference is important to assess how efﬁciently
terminators can isolate the transcriptional regulation of two
adjacent genes.
Box 1 Competitive and non-competitive inhibition of
gene expression
Two basic forms of inhibition of gene expression are described by simple
equilibrium models. When an inhibitor, R, interferes with the binding of the
transcriptional activator, A, inhibition of gene expression is competitive.
Expression is given by
Ex ¼ w
A
KA
Dð1 þ fðRÞÞ þ A
ð1Þ
KD
A isthedissociationconstantoftheactivatorbinding,wisaproportionality
constant, whereas f(R) is a lumped parameter incorporating the
concentration and the dissociation constant of the inhibitor.
If the inhibitor does not prevent the activator from binding to the
promoter, but suppresses transcription at a later stage, inhibition is non-
competitive. A more general model incorporates the synergistic binding of
the activator and the inhibitor, as well.
Ex ¼ w
A
KA
D þ A þ KA
DfðRÞþaAfðRÞ
ð2Þ
a denotes to what extent more likely is the joint binding of the activator and
inhibitor than the binding assuming no interaction between them.
Characteristic proﬁles of inhibition, across a broad range of expression
levels, can be conveniently compared when the fold change of expression
due to a ﬁxed concentration of the inhibitor is calculated as the activator
concentration is varied. For this purpose, fold inhibition-1 was plotted
against normalized expression (see Materials and methods section).
Normalized expression, NE, corresponds to the expression, Ex, calculated
in the absence of the inhibitor (f (R)¼0, w¼1 in equations (1 and 2));
NE¼A (KD
AþA)
 1.
Competitive inhibition is shown for KD
A¼0.043, f(R)¼3.8 in equation (1).
When gene expression approaches saturation, fold inhibition-1 drops
rapidly, because the activator does not increase the expression noticeably
but can increasingly outcompete R. However, fold inhibition-1 doubles at
most, when the normalized expression is reduced from 0.5 to an arbitrary
low value. For the supercompetitive mechanism, fold inhibition-1 increases
more than twice when the normalized expression is reduced from 0.5 to an
arbitrary low value. The supercompetitive curve is plotted for KD
A¼0.043,
f1(R)¼0, f2(R)¼0.1 and a¼0.011 using equation (4) given by Ratna et al,
2009. Supercompetitive inhibition arises when the activator and the
repressor jointly determine the permissive state of the promoter (Ratna
et al, 2009).
For non-competitive inhibition, fold inhibition-1 has a constant value as
transcriptional activation is varied (the curve is shown for KD
A¼0.043,
f(R)¼2 and a¼1 in equation (2)). When R and the activator bind
cooperatively (KD
A¼0.043, f(R)¼0.5 and a¼4 in equation (2)), fold
inhibition-1 decreases with decreasing transcriptional activation (also see
Supplementary Figure S3).
Supercompetitive 
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activation when it was inserted directly downstream of a UAS
that had no TATA box associated with it (Figure 1F). This
suggests that terminators do not prevent an activator from
initiating transcription at a TATA box positioned downstream
of the terminator (Figure 1F), but they terminate transcription
that had been fully initiated (Figure 1D).
Genome-wide analyses of gene expression suggest
that genes may not reach their optimal expression level
because of interference of their genomic environment (Liao
and Zhang, 2008); and evolution proceeds in a direction to
increase intergenic distances, whereby interference is reduced
(Chiaromonte et al, 2003; Byrnes et al, 2006). Indeed, the
simple DNA sequence requirements for the interference to be
initiated(SupplementaryFigureS13B)and,thegood,butﬁnite
(B80%), efﬁciency of transcriptional termination between
adjacentgenesmaycontributetothewidespreadoccurrenceof
interference in the genome.
Downstream antagonism
To study antagonism by downstream activators, activator-
binding sites were inserted downstream of the TATA box in the
promoter–GFP constructs. Binding of GEV to the upstream
site, GALUAS, drove the expression of GFP (Figure 3A). The
binding of rtTA to tet operators downstream of a TATA box
inhibited GFP expression (Figure 3A). This indicates that in
addition to DNA-binding protein domains alone (Brent and
Ptashne, 1984; Murphy et al, 2007), full-length transcriptional
activators can interfere with the transcriptional activation.
Expression data at different strengths of downstream antagon-
ismwereinexcellentagreementwithanequilibriummodelfor
non-competitive inhibition that incorporates the cooperative
binding of GEV and rtTA (Box 1, Figure 3A and B) (Cornish-
Bowden, 2004). Cooperative binding of rtTA to promoters has
been observed (Becskei et al, 2005). The cooperative interac-
tion between the upstream and downstream sites could
account for the observation that at a low estradiol concentra-
Figure3 Downstreamantagonism. TheTATAboxisdenotedbyacheckered diamondinthegeneticconstructs.Errorbarsrepresent s.d.valuescalculatedfromthree
experiments, unless otherwise speciﬁed. (A) Expression driven by PGALUAS-TATA-tetO2 (RUY20) in the presence of different ﬁxed concentrations of doxycycline. The
curves were obtained by ﬁtting equation (2) (Box 1): KD
A¼0.067, a¼3.2. f(R)¼0.31 and 1.05 for respective doxycycline concentrations (B) Scheme of non-competitive
inhibition. When the AUAS and ADI activators bind to the promoter simultaneously, no transcription is initiated. (C) Expression driven by PGALUAS-TATA-FUS1UAS
(YABH42.1) inthe presence of different ﬁxedconcentrations of a-factor.The FUS1UAS containsthreebinding sites forthe endogenous Ste12p transcriptional activator.
Expression was adjusted using the PGALUAS-TATA-MutFUS1UAS construct (YABH43.2) to account for the nonspeciﬁc effects of a-factor on expression (see Materials and
methodssection).Thecurvesareﬁtstothenon-equilibriummodelofthedownstreamantagonism(seeSupplementaryInformation,SEq2)withpUAS¼0.01nM
 1min
 1,
pDI¼0.005nM
 1min
 1, a¼32.8, m1¼0.07min
 1, m2¼0.1min
 1, p3¼1min
 1, m3¼0.2min
 1 and k¼0.2min
 1, Atot¼500nM, Kind¼2161nM, vmax¼619; [ADI]¼0,
0.89,2.79and4.46fortherespectivea-factorconcentrations.(D,E)ContourplotsrepresentexpressionlevelsasafunctionofADIandAUASusingtheparametervalues
asin(C),exceptforpDI¼0.01nM
 1min
 1,andthecooperativityofbinding,awasvaried:a¼1(D)anda¼20(E).(F)ExpressiondrivenbythePtetO7-TATA-tetO2(RUY65)
and PtetO7-CYC1TATA (RUY67.13) constructs. LacZ was used to detect gene expression with higher sensitivity. Expression of the PTATA-tetO2 construct (RUY69), which
lacks an upstream activation sequence, is below the detection limit. The value for s.d. is calculated from two experiments. The bell-shaped curve was obtained by ﬁtting
SEq. 4 (w¼470, n¼m¼1.2, N¼0.46 and M¼0.79). Source data is available for this ﬁgure at www.nature.com/msb.
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non-competitive inhibition.
To further explore the cooperative interaction between
multiple binding events, three binding sites were inserted
downstream of the TATA box, which are recognized by the
Ste12p activator (Figure 3C). Ste12p activates its target
genes when induced by a-factor, but it inhibits the expression
of the PRY3 gene by binding to a downstream site (Bickel
and Morris, 2006). When the expression of the resulting
PGALUAS-TATA-FUS1UAS construct was induced by high concentra-
tion of estradiol, addition of a-factor inhibited transcription in
a dose-dependent manner (Figure 3C). However, at lower
estradiol concentration, expression was paradoxically in-
creased in response to increasing a-factor concentrations. This
illustrates that interference in the same genetic construct can
result in both inhibition and activation. Correspondingly,
Ste12p buffers the action of GEV when induced by high
concentration of a-factor, as expression changes only slightly
over a broad range of estradiol concentrations.
Theparadoxicalactivationcanbeexplainedwhentheabove
model was modiﬁed so that the activator bound to the
downstream site induced a weak expression indirectly by a
non-equilibrium kinetic effect on the upstream activator or
directly by recruiting the transcription initiation machinery
(Figures 3C and Supplementary Figures S4–S6).
Cooperative interactions are typically considered to be
advantageousforregulation.Forexample,cooperativebinding
of repressors increases the sensitivity of response, making
repression respond to environmental stimuli in a switch-like
manner (Oehler et al, 2006). Thus, the reduction of inhibition
by the cooperative interaction of the two antagonistic
activators seems rather disadvantageous for regulation.
However, a two-dimensional input plot reveals that the
cooperativity renders the response more square-like, so that
high expression is restricted to a quadratic domain in which
the occupancy of the upstream sites is high and that of the
downstream sites is low (compare Figure 3D and E).
A genome-wide search retrieved many activator-binding
sites downstream of a TATA box that are conserved in related
yeast species (Supplementary Table S1). Some of these sites
may regulate gene expression. A Mac1p-binding site down-
stream of the TATA box of the FTR1 promoter inhibited gene
expression, and activated expression when transferred to an
upstream site (Supplementary Figure S15). This ﬁnding may
explaininpartwhythedeletionofMac1p,acopper-responsive
transcriptional activator, results in an increase in FTR1
expression (De Freitas et al, 2004).
In all the retrieved promoters (Supplementary Table S1),
a single binding site downstream of the TATA box was
identiﬁed. Therefore, downstream antagonism is expected
to follow the non-competitive inhibition with cooperative
binding (Figure 3A).
Bell-shaped response
Both the equilibrium and non-equilibrium models predict that
binding of the same activator to both the upstream and
downstream sites generates a bell-shaped response (Supple-
mentary Figure S7). When rtTA binds to tet operators ﬂanking
the TATA box, increasing doxycycline concentration resulted
in a bell-shaped response: expression initially increased and
after reaching a plateau, it declined (Figure 3F, Supplementary
Figure S16). The peak expression in the bell-shaped response
is around ﬁve times less than the maximal expression of the
corresponding expression cassette containing the upstream
activation sequence only, conﬁrming the predictions of the
model. As the bell-shaped response limits gene expression to a
narrow range of inducer concentrations it has the ability to
translate concentration gradients into localized expression
patterns, similar to the stripe formation during embryonic
development (Sanchez and Thieffry, 2003; Basu et al, 2005).
This response is reminiscent of the output of gene circuits
withfeed-forwardloops(ManganandAlon,2003;Kaplanetal,
2008).
The regulatory architecture of the ZRT2 promoter is very
similar to our construct that generated bell-shaped response
(Figure 3F). The Zap1p activator binds to sites ﬂanking the
TATA box of the ZRT2 promoter. Although prior experiments
have focused on repression by Zap1p, the full data set is
compatible with a bell-shaped response to zinc (Supplemen-
tary Figure S17) (Bird et al, 2004). This similarity underscores
the utility of studying signal processing by synthetic circuits to
understand the functioning of natural gene networks.
Conclusions
It is essential to know to what extent gene expression can be
inhibited as transcriptional activation is varied to understand
gene regulation and to design gene expression systems for
biotechnological purposes. Simple equilibrium models were
consistent with most of our observations. In particular non-
competitive inhibition with cooperative binding is consistent
with the ﬁndings on downstream antagonism, including the
bell-shapedresponse,whichhasbeenobservedinthegenomic
context as well (Bird et al, 2004). The equilibrium approach is
frequentlyusedtodescribegeneregulationwhentranscription
factors bind to promoters, because binding is a reversible
process and rapid relative to the kinetics of the reporter gene
expression. A more complex non-equilibrium model is
realistic to explain interference, for which the regulator is
transcription itself. Transcription is a highly irreversible
process as the elongating polymerase proceeds only in one
direction. This energy consuming interfering polymerase
regulates the expression of the gene it traverses. Therefore, the
non-equilibrium approach can capture the irreversible nature
of processes having a function in upstream interference.
Interestingly, intergenic transcription inhibits the expression at
PtetO2-CYC1TATAlessefﬁcientlythanatPtetO2-GAL1TATA,e venthou gh
rtTA has nearly equal afﬁnities for these promoters (Figure 2B).
Theﬁttednon-equilibriummodelsuggeststhatrtTArebindsand
restores the initiation complex more rapidly at PtetO2-CYC1TATA,
after the polymerase traverses the promoter. This may explain
why the expression at PtetO2-CYC1TATA is more resistant to
interference.
Our ﬁndings reveal unexpected links between different
forms of transcriptional regulation. Both upstream interfer-
enceandclassicalrepressionbyrepressorproteinsinyeastrely
on competitive inhibition even though they represent distinct
molecular mechanisms (Ratna et al, 2009). These simple
Antagonism of transcriptional activators
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complex responses in the genomic context.
Materials and methods
Genetic constructs
GEV is a fusion protein consisting of the Gal4p DNA binding domain,
an estradiol receptor domain and the transcriptional activation
domain, VP16-AD (Louvion et al, 1993). rtTA is a fusion of the rtetR
DNA binding domain and the VP16-AD (Urlinger et al, 2000). The
rtetR–(NLS-AD)
Swi5 fusion was obtained by linking the following
DNA sequences: rtetR(S2)(1–643), GGGCGCGCC, SWI5(1900–2125),
CCTGCAGGG and SWI5(4–1639). rtTA(S2) served as a template for
producing rtetR(S2). We used the enhanced green and the yellow
variants of the greenﬂuorescent protein as speciﬁed in Supplementary
Table S2.
Yeast strains and growth conditions
All strains are congenic with W303 (ade2-1, leu2-3, ura3, trp1-1,
his3-11,15 and can1-100). Genetic constructs were integrated into the
chromosome (Supplementary Table S3).
Cells containing inducible gene expression constructs were grown
for 5h after induction in minimal medium, until a cell density
of OD600¼0.4–0.8, unless speciﬁed otherwise, was attained. When
a-factor was added to cell culture at OD600¼0.025, cells were grown
for 200min.
Co-expression of GEVand rtTA did not affect the growth rate of the
cells and the percentage of cells that lost the constructs containing the
reporter gene and rtTA was o0.01% (Supplementary Figure S14).
b-Galactosidase assay
b-Galactosidase activity was measured using cell extracts obtained
from freeze–thaw cycles and CPRG was used as a substrate.
Flow cytometry and calculation of expression
Total ﬂuorescence of, at least, 5000 cells was measured using ﬂow
cytometry. About 5–15% of total cell population was selected in the
forward-scatter versus side-scatter plot to measure GFP ﬂuorescence
of cells with similar size. To calculate expression (Ex), the total
ﬂuorescence of GFP expressing cells (Fe,d) was divided by the
background ﬂuorescence of a control strain (FC), which expresses
lacZ only:
Exe;d ¼
Fe;d
FC
  1
The e and d subscripts refer to the applied concentration of estradiol
and doxycycline, respectively.
The a-factor causes changes in the forward and side scatter of the
cells in a concentration-dependent manner, and also in the expression
level induced by estradiol. The latter effect of a-factor may be caused
directly by changes in general transcriptional rates and/or indirectly
caused by changes in cell growth and consequently in dilution rate of
GFP. Therefore, expression was corrected by the expression of a
constructinwhich theSte12p-bindingsitesweremutated(YABH43.2):
Exe;a ¼
FWe;a
Ca   1

FMe;0
C0   1

FMe;a
Ca   1
where C0 and Ca denote the control cell ﬂuorescence at zero and the
applied a-factor concentration, respectively. FWe,a and FMe,a denote
GFP ﬂuorescence of constructs with wild-type and mutant Ste12p
binding sites, respectively. FMe,0 corresponds to FMe,a, when a¼0.
The background expression is typically low and is subject to large
relative ﬂuctuations when exposed to interference, which makes it
difﬁcult to discern the effect of interference when gene expression is
not induced (Supplementary Table S4).
Data analysis
Normalized expression, NE, is the uninhibited expression at a given
degree of activation divided by the maximally induced expression:
NE0;d ¼
Ex0;d
Ex0;dmax
forupstreaminterference
NEe;0 ¼
Exe;0
Exe max;0
fordownstreamantagonism
For upstream interference dmax¼20mM; for downstream antagonism
emax¼200nM. Fold inhibition at a given point of normalized expression
was obtained by dividing expression in the absence of antagonism by the
expression suppressed by the antagonistic activator:
FIe;d ¼
Ex0;d
Exe;d
forupstreaminterference
FIe;d ¼
Exe;0
Exe;d
fordownstreamantagonism
The characteristic proﬁles of weak inhibition on logarithmic plots are
better displayed with fold inhibition-1 than with fold inhibition.
The termination efﬁciency, TE, was calculated by
TE ¼ 1  
FIeðTÞ 1
FIeðNTÞ 1

 100
FIe denotes the fold inhibition of expression owing to the presence of
estradiol.TandNTintheparenthesesstandfortheconstructswithand
without transcriptional terminator, respectively.
Model ﬁtting
When the intergenic transcription was strong, the equilibrium
competition model did not approximate well the full data set
(Supplementary Figure S10), although it agreed well with the data
obtained at high concentrations of doxycycline (Figure 2B and C). In
such cases, the equation was ﬁtted to only those data points that had
a normalized expression higher than 0.4. This approach exposes
how the remaining data points, obtained at lower doxycycline
concentrations, deviate from the competition model. Subsequently,
the competition model can be complemented parsimoniously.
To ﬁt the non-equilibrium models to the experimental data, the
concentration of the functionally active transcriptional activator, AUAS,
has to be extrapolated from the inducer (estradiol or doxycycline)
concentration, ind, and the total activator concentration, Atot.
AUAS ¼ Atot
ind
Kind þ ind
Kind is a lumped equilibrium constant and represents the transport of
theinduceracrossthecellmembrane,andthebindingoftheinducerto
the activator. Its ﬁtted value depends also on the activity ﬂuctuations
of the inducer.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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